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Abstract
The diagnosis of toxoplasmosis is of great importance due to the damage caused by this 
parasite in immunosuppressed people or in pregnant women, the diagnosis of an active 
toxoplasmosis represents a sign to initiate a pharmacological treatment immediately. The 
diagnosis of Toxoplasma can be performed with direct methods through intraperitoneal 
inoculation of serum or cerebrospinal fluid, in susceptible mice evaluating the survival 
and detection of tachyzoites of biological samples. Indirect methods detecting the IgM and 
IgG isotypes against Toxoplasma have been the tools mostly used and had leaded to discrimi-
nate between an active and acute, from a chronic toxoplasmosis. Molecular methods actually 
Toxoplasma-DNA identification by molecular biology tests like the polymerase chain reac-
tion (PCR) allow the direct detection of the parasite. Polymerase chain reaction-restriction 
fragment length polymorphisms (PCR-RFLPs) have been used to identify three strain lin-
ages (type I, II and III). Recently, a high-resolution melting method was described to deter-
mine the genotype of the infection by Toxoplasma gondii directly from biological samples.
Keywords: Toxoplasma infection, diagnosis, toxoplasmosis, methods
1. Introduction
The diagnosis of toxoplasmosis represents a very important decision to whether to initiate or not 
an anti-parasitic treatment. The immunological methods that detect the IgM and IgG isotypes 
against Toxoplasma have been the tools mostly used and had leaded to discriminate between acute 
and chronic toxoplasmosis. In immunosuppressed people or in pregnant women, the diagnosis 
of an active toxoplasmosis represents a sign to initiate a pharmacological treatment immediately.
Several methodologies have been applied historically, including the isolation of the parasite in 
biological specimens and the xenodiagnostic evaluation through intraperitoneal inoculation 
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of serum or cerebrospinal fluid, in susceptible mice evaluating the survival and detection of 
tachyzoites in cerebrospinal fluid. Serologic diagnosis is frequently performed for the detection 
in serum of IgM and IgG anti-Toxoplasma antibodies, and recently Toxoplasma-DNA identifica-
tion by molecular biology tests is the polymerase chain reaction (PCR) that allows the detection 
of just 10 or less parasites in the reaction volume.
2. Direct methods
2.1. Isolation of the parasite or bioassay
The diagnosis of toxoplasmosis could be performed by the inoculation of suspicious blood 
samples, cerebrospinal fluid, lymph node or other corporal fluids or tissues, in the peritoneal 
cavity of the immunosuppressed mice or in a susceptible strain like BALB/c. The presence of 
tachyzoites in the peritoneal fluid of the mice is analysed by phase contrast microscopy from 
6 to 10 days after inoculation. The parasite is observed in its characteristic half-moon fixing 
the specimen with methanol and stain with Wright, Giemsa or May-Grunwald and observed 
by a microscope. The parasites present sometimes a granular membrane, dyed blue cyto-
plasm and a red nucleus at the center of the cytoplasm.
In cases of new-borns with toxoplasmosis, inoculation of mice with blood of the child obtained 
during the first week of birth reaches 75% of positive results; however, if the sampling is 
delayed by 1 month, the positive results are reduced to 52%. A drawback of this method 
is the need of specialized personal because of the risk of contamination by the handling of 
Toxoplasma, as well as the lapse of time to get the results [1–5].
2.2. Cellular culture
Cellular culture is more utilized nowadays for the diagnosis and isolation of parasite in vitro 
[5, 6], the parasite has been isolated from lung [5, 6] and cerebrospinal fluid from patients 
with acquired immunodeficiency syndrome (AIDS) [7]. Diagnosis by cellular cultures has 
also been utilized in ocular toxoplasmosis [8, 9]. Cellular cultures are also used for research 
purposes, like the study of host-parasite interaction, identification of factors involved on 
innate resistance, molecular and genetic characterization of Toxoplasma strains [10] and for 
the evaluation of candidate molecules on vaccine and treatment development [11].
The cell culture to identify tachyzoites from biopsy or corporal fluid of infected patients, leads 
to the destruction of the cellular monolayer and is related with the initial amount of tachyzo-
ites in the biological sample. The sensitivity of parasite detection by cell culture from intra-
ocular liquid (aqueous and vitreous humor) is 91%, compared with antibodies detection by 
ELISA with 67%.
2.3. Histology
The detection of tachyzoites in histological sections from suspicious biopsies indicates an acute 
infection; on the contrary, the detection of tissue cysts that contain bradyzoites in histological 
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samples only confirms a chronic toxoplasmosis infection. The presence of cysts in the pla-
centa, foetus or new-born indicates a congenital infection, according to the number of cysts in 
histological sections, can be suggested as an active infection and needs immediate treatment. 
In biopsy or autopsy material, the encysted tachyzoites and bradyzoites are usually demon-
strable with wright, hematoxylin and eosin dyes, where the bradyzoites contain glycogen vac-
uoles. The size of the cyst is important in histological sections of the brain (Figure 1). There are 
other stain techniques like Schiff-periodic acid, specific immunohistochemistry stained with 
inmunoperoxidase that are equally efficient. These procedures have great diagnosis value but 
are limited due to the difficulty to grow parasites in vivo as well as the identification of tachyzo-
ites by histochemistry methods [3, 5, 8].
3. Immunodiagnostics’
3.1. Sabin and Feldman test
The Sabin and Feldman reaction, also known as the dye test [12], is considered as golden stan-
dard by detection of Toxoplasma-specific antibodies. The patient’s serum is mixed with a sus-
pension of live tachyzoites, and then methylene blue dye is added. If the patient’s serum has 
anti-Toxoplasma antibodies, by the effect of complement factors, the parasites are lysed losing 
the property of capturing the dye, and as a result they are observed without colour under the 
Figure 1. (A) Tachyzoites from mice peritoneal exudate, Diff-Quick stain, 100×. (B) Tachyzoites from mice peritoneal 
exudate, alkaline metilen blue, 10×. (C) Multiply tisular cysts en mouse brain, without stain, 20×. (D) Tisular cyst in 
mouse brain, Diff-Quick stain, 40×. (E) Histological section of the necropsy from patient (400×) cyst of Toxoplasma 
gondii in the sarcoplasm of a cardiac muscle fiber. (F) Histological section of the necropsy from patient (400×) H&E 
stain, in which some cysts of Toxoplasma are observed in the alveolar epithelium, necrosis in the adjacent cells, detritus, 
some inflammatory cells and proteinaceous material H&E stain. (A–D) Courtesy of Gustavo Salas Lais. Student of 
Doctoral Science in Biomedicine and Molecular Biotechnology, ENCB-IPN.Mexico. (E and F) Courtesy of Dr. Ramón 
Franco Topete: Medical Pathologist, Department of Microbiology and Pathology CUCS and the New Civil Hospital of 
Guadalajara, Mexico.
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microscope (positive result for toxoplasmosis). When there are no anti-Toxoplasma antibodies 
in the assayed serum, the parasites remain with their cellular layer intact and thereby capture 
the dye showing a blue colour under the microscope (negative result to toxoplasmosis). The 
problem with this test is the use of live tachyzoites, a potential risk to laboratory staff conduct-
ing the test. Also, it requires specialized infrastructure for the maintenance of the parasites, so 
only research and reference centres perform this diagnostic tool [12]. Interpretation of results 
shows that the parasites dyed blue (negative) and more than 50% non-dyed (positive) para-
sites are reported with the highest serum dilution with the positive result, and the values that 
reflect infection with the parasite are >1:16 IU.
3.2. Hemagglutination
The hemagglutination assay was first described by Jacobs L. in 1957. This test is based on the 
capacity of anti-Toxoplasma gondii antibodies to agglutinate sensitive erythrocytes masked with 
cytoplasmic Toxoplasma antigens [13, 14]. This test is useful, rapid and highly sensitive ideal to be 
used in association with indirect immunofluorescence [15]. Also, it could interfere in the diagnosis 
of congenital toxoplasmosis, as the identified antibodies are IgG and so on. Interpretation of the 
test: positive if agglutination is present and negative if the agglutination is inhibited. The result 
is considered the lecture at the higher dilution. Afterwards Yamamoto in 1991, standardized a 
test for the determination of IgM antibodies, with a sensibility of 98% and specificity of 95% [16].
3.3. Modified agglutination test (MAT)
For this assay, the tachyzoites are fixed with formaldehyde in microtiter plates in the form 
of U plates with diluted serum added. In positive serum samples, a thin layer of agglutina-
tion is produced, while in negative samples compact sediment is formed due to precipitated 
tachyzoites at the bottom of the well. This assay was first described by Fulton and Turk [17], 
with low specificity and sensitivity, due to the union of normal IgM at the surface of the para-
site and improved by the preparation of the antigen using a buffer with 2-mercaptoethanol, 
that eliminates the non-specific IgM. This assay detects IgG antibodies, without limitation of 
host species, but false negative results could occur during early stages of acute infection [17]. 
The specificity and sensitivity of MAT are similar to the Sabin and Feldman assay in most spe-
cies. Also, MAT can be used in corporal fluids, being of much used in field work.
3.4. Indirect immunofluorescence (IFI)
This assay was described by Garin in 1967 [18], consists of fixation of tachyzoites on micro-
scope slides. Upon contact with the antibodies present in the patient’s serum, the antibody 
antigen reaction is carried out, which is visible with a second antibody labelled with fluo-
rescein. The antigen-antibody reaction is evidenced by fluorescence microscope. In positive 
cases, a bright yellow greenish fluorescence is evident and a red colour without fluorescence 
is observed in negative cases. The colour of the fluorescence depends on the fluorochrome 
conjugated to the antibodies. The immunofluorescence is a test that shows high precision 
when it is adapted for specific antibodies. It is known that when the human is infected, 
it responds first with the production of IgM that disappears later. The detection of specific 
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IgM in the new-born shows difference in the antibodies transmitted from the mother to the 
product (IgG goes through placental barrier and IgM is not capable to do it). The detection 
of specific IgG contributes to the diagnosis most of the times; however, considerable titles of 
antibodies may persist for months or years [18].
3.5. Enzyme linked immunosorbent assay (ELISA)
The enzyme linked immunosorbent assay (ELISA) was described initially in 1971 by Engvall 
and Perlman, uses antibodies conjugated to an enzyme [19]. The antibody conserves its capac-
ity of specific union to the antigen, while the enzyme is capable of a redox reaction, in which 
the substrate precipitates in a coloured product. In this system, the antigen or the antibody is 
absorbed to an insoluble solid phase (micro polystyrene plates). There are several variants of 
ELISA: direct, indirect, capture and competitive. All of them allow the determination of anti-
gens in biological fluids except the indirect method that only detects antibodies.
The direct ELISA methods involve attachment of the antigen to the solid phase, followed by an 
enzyme-labelled antibody. This type of assay generally makes measurement of crude samples 
difficult, since contaminating antigens compete for plastic binding sites. Whereas, indirect 
ELISAs also involve attachment of the antigen to a solid phase, but in this case, the primary 
antibody is not marked. An enzyme-conjugated secondary antibody, directed at the first anti-
body, is then added. This format is used most often to detect specific antibodies in serum.
The captured ELISA assay involves attachment of a captured antibody to a solid phase support. 
Samples containing known or unknown antigens are then added in a matrix or buffer that will 
minimize attachment to the solid phase. An enzyme-labelled antibody is then added for detection.
The most used enzymes are horse radish peroxidase (HRP), alkaline phosphatase (FA) and 
the β-d-galactosidase (BG), the substrates for the HRP enzyme are hydrogen or urea per-
oxide, which on reducing make certain chromogens oxidized in the enzymatic reaction, 
developing a coloured product. The oxidized ortho-phenylene diamine remains soluble 
after the oxidation reaction and is the most used. The FA substrate p-nitrophenyl phos-
phate that produces colour when degraded by the enzyme at temperatures over 30°C, the 
5 bromo-4cloro-3-indoilphosfate can be employed in ELISA in tube or in dot-ELISA. The 
ELISA method detects from 70 to 80% of cases in congenital infections, a rise in the titles of 
IgM that extends more over the first week is indicative of acute infection, since the average 
of duration of maternal IgM is from 3 to 5 days. Also, antibodies can be determined in serum 
and aqueous humour.
Interpretation of the test: If ELISA is qualitative, a development of colour is observed in sero-
positive samples. If the test is quantitative, the intensity of the developed colour is measured 
at a determined wavelength (nanometres) and the lecture of absorbance is proportional to the 
magnitude of the reaction antigen-antibody [20–22].
3.6. Recombinant antigens
At the final of the nineteenth century, several recombinant antigens of different sites of the 
parasites were analysed [23, 24]. The dense granule antigen—GRA1, GRA2, GRA4, GRA6, 
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GRA7 and GRA8, rhoptries protein—ROP1 and ROP2, the matrix protein—MAG1, protein 
micronemes—MIC2, MIC3, MIC4 and MIC5 or the surface antigen—SAG1 and SAG226, 
were evaluated as diagnostic markers in human beings or animals by ELISA to detect IgG 
and IgM specific antibodies [25]. The combinations of recombinant antigens have showed 
more sensibility and specificity for the use of only one antigen. For example, the combina-
tions of SAG2A, GRA2, GRA4, ROP2, GRA8 and GRA7 are potentially useful to detect anti-
bodies IgG in human beings with the infection recently acquired [26], ROP1, SAG1, GRA7, 
GRA8 and GRA6 are promising to detect specific IgM antibodies while GRA7 and GRA8 are 
used to detect IgA specific antibodies. A specific protein of sporozoites related with embryo-
genesis (TgERP) was identified in a study, it can react with specific antibodies of oocysts 
and can be used to detect an early infection by sporozoites implying the oocysts as infection 
source [27, 28].
3.7. Avidity test
The IgG avidity test was described by Hedman et al. [24]. This assay measures the avidity 
of the binding of specific antibodies to T. gondii antigen. The proteins present in the serum 
are denatured with a solution of urea. The avidity can be variable during the course of 
infection [29, 30]. In early stages of infection, the values of avidity are low and are increas-
ing with the course of infection [24]. Therefore, the avidity test can distinguish between 
acute and chronic infection. The assay is performed by different serological procedures, 
such as ELISA. However, there are limitations for the IgG test in pregnant women, since 
these antibodies can persist for several months and the treatment of T. gondii can affect the 
results [31].
3.8. Western blot
Western blot is an immunoenzymatic technique, based on the binding of Toxoplasma antigens 
fixed on nitrocellulose paper with specific antibodies present in the serum of infected patients. 
First, the protein antigens must be separated by electrophoresis in polyacrylamide gel (PAGE-
SDS), then transferred and immobilized in a solid phase (nitrocellulose layer). Nitrocellulose 
paper must be blocked or saturated with non-antigenic protein (bovine serum albumin) to 
prevent the unspecific binding of the antibodies. Then a second antibody conjugated with 
an enzyme (horseradish peroxidase or alkaline phosphatase) is added, this antibody binds 
to the Fc of the first antibody, when the substrate of the enzyme is added. The substrate is 
transformed to a product and visible specific bands in situ indicate the antigens of T. gondii 
recognized by specific antibodies [32].
Western blot has the advantage to identify specific antigens recognized by IgG, IgM and IgA 
antibodies from serum and cerebrospinal fluid of patients with chronic and acute toxoplas-
mosis, specially in immunocompromised patients with low titers of antibodies. In immuno-
competent patients this method has been used to identify parasite proteins as markers for 
toxoplasmosis diagnosis (Figure 2) [33]. Also, diagnosis of congenital toxoplasmosis from 
colostrum samples by Western blot is very useful, since IgA antibodies recognize a greater 
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number of antigens [34]. This method has also been used with other corporal fluids such as 
saliva [35].
3.9. Immunocytochemistry and immunohistochemistry
The immunocytochemistry involves detection of epitopes expressed by the antigens of 
Toxoplasma within a tissue sample using a ‘primary antibody’ capable of binding those epit-
opes with high specificity. After the epitope-antibody binding event, a ‘secondary antibody’ 
capable of binding the primary antibody with high specificity is added. The secondary anti-
body is coupled to a reporter molecule and after the antibody-antibody binding event, a 
chemical substrate is added which reacts with the reporter molecule to produce a coloured 
precipitate at the site of the whole epitope-antibody complex (Figure 2B). The immunohis-
tochemistry has the same base as that of the immunocytochemistry, the difference is that 
this one is realized on tissue slides. Studies have been done for a neuropathological test of 
cerebral tissue in patients with infection by the virus of human immunodeficiency VHI/AIDS, 
to evaluate the diffuse and spread brain multifocal lesions [36]. With immunohistochemistry 
there have been realized studies in different tissues to demonstrate T. gondii, such as ocular 
toxoplasmosis [37–39].
4. Molecular techniques
4.1. Generalities of the genome of T. gondii
Molecular biology has permitted the advance in molecular knowledge of T. gondii. Its genome 
contains approximately 65 megabases (MB), distributed in 14 chromosomes which varies 
from 1.9 to 7.4 MB. It contains 52.3% of GC and codifies for almost 7988 proteins and contains 
Figure 2. Recognition pattern of antibodies IgG and IgM by Western blot. The antibodies IgG and IgM were detected in 
samples of serum from a patient with acute infection. Negative control (−), positive control (+), samples 1 and 2 correspond 
to the bands of antigen T. gondii revealed by specific antibodies type IgG and IgM.
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296 small non-coding genes (Ensemble protists): T. gondii: [40, 41]. The complete genome 
sequence of GT1, ME49 and VEG strains classifies the Toxoplasma in three types I, II and III, 
respectively. Till date, the analysis of the restriction fragment length polymorphisms (RFLPs) 
with more than 900 strains of the parasite permits its classification in 140 genotypes grouped 
in 12 main groups. Similar results were obtained by the sequencing of introns of a smaller 
number of samples and also using microsatellite markers. In spite of these results, it is neces-
sary to sequence more complete genomes for a better precision in the clarification of the lin-
ages (information taken in the page of Institute J, Craig Venter) [42].
4.2. Molecular diagnosis by the polymerase chain reaction (PCR)
The polymerase chain reaction (PCR) consists in making a repetitive replication in vitro of 
specific DNA sequences. Amplifying or copying several times a fragment of DNA, the ana-
lytical sensibility of the test increases proportionally. The amplified product is analysed by 
electrophoresis in agarose or polyacrylamide gel. This technique is useful in the detection of 
the parasite in serum samples, peripheral blood mono-nuclear cells (PBMC), urine, placenta, 
amniotic and spinal brain liquid. The sensibility and specificity of PCR depends on the tech-
nique used in the extraction of DNA, the primers and the parameters of the amplification 
reaction [43, 44]. The most conserved genes of Toxoplasma are B1 with 35 copies in the genome 
of the parasite, followed by the repetitive region REP of 529 base pairs (bp) with an approach 
of 300 copies in the genome; these genes are the most selected for the PCR test as diagnostic 
tool. Other sequences of unique copy, which are used in investigation laboratories mainly for 
genotyping purposes are SAG1, SAG2, SAG3, SAG4 and GRA4 genes [45]. The polymerase 
chain reaction (PCR) is a very valuable diagnosis method in acute infections, when the para-
site crosses placental barrier and infects the foetus or on infected patients with AIDS and other 
immunosuppression or reactivation of the parasite [46–48]. Unfortunately, it is difficult to 
have a confidentially valor in the PCR assays. For a pre-natal diagnosis, the reported sensibil-
ity goes from 64 to 97.4% with a predictive negative value of 87.7–99.7%, respectively; in case 
of patients with AIDS and toxoplasmosis, the reported sensibility goes from 13 to 87.5% [49]. 
With the detection of the sequence REP 529-bp, a sensibility of 100% has been reported in 
amniotic fluids [48]. The sequence REP 529-bp is having an increase in the utility for the diag-
nosis of T. gondii by PCR since it demonstrates greater sensibility, possibly the high number of 
repetitions in the parasites sequence increases the possibilities of detection. The variations in 
the results are due to different time of infection in the patients, type of sample, storage condi-
tions that affect sensibility. Also, actually there is no agreement in the primers that should be 
used in the PCR, one of the regions which is more conserved is gen B1 [47], still there exists 
some polymorphisms and the strains of Toxoplasma in clinical samples are not the same geno-
type, these factors can affect the parasite detection. It requires large number of studies which 
compare gen B1 and the sequence REP 529-bp to meet and agreement in the selection of prim-
ers. Another factor that can affect the results is the variability reported in the techniques used 
for DNA extraction.
In patients with AIDS, the detection of T. gondii by PCR in cerebrospinal liquid has shown 
different sensibilities, reaching to 87% of sensibility when the sample is taken soon enough 
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preferably during the first 3 days and a maximum of 7 days after starting the specific 
 treatment [48].
The polymerase chain reaction (PCR) can be in the future, undoubtedly a successful tool in 
the diagnosis of toxoplasmosis, when a satisfactory correlation exists between the patient’s 
clinical profile and the presence of T. gondii DNA aspects which still have to be studied and 
standardized. Also, in countries with low development and still in many with high develop-
ment, it has not been implemented for daily use due to its high cost.
4.3. PCR in real time
Unlike the conventional PCR, the real-time PCR using fluorescence probes measures the 
product of amplification in each cycle and can be quantified with the use of known con-
centration standards. Real-time PCR has been successfully used to detect the T. gondii 
DNA in human blood, cerebrospinal fluid, aqueous humour, amniotic liquid and other 
samples [49–51]. Also, it is used to evaluate the progression of the toxoplasmosis and the 
efficiency of the treatment, since it can estimate the intensity of the infection by T. gondii. 
The PCR assay in real time with REP 529-bp sequence is considered as the technique with 
greater efficiency for the diagnosis of toxoplasmosis in comparison with the detection of 
gen B1.
4.4. Loop mediated isothermal amplification (LAMP)
Loop mediated isothermal amplification (LAMP) is a technique of DNA amplification 
under isothermal conditions, which combines speed, efficiency and high specificity. The 
amplification of DNA proceeds from the repetition of two reactions of elongation in a 
structure that has loop form. It uses DNA polymerase with strand displacement activity 
and two inner primers and two outer primers. The inner primers contain sense and anti-
sense sequences of DNA and initiate the LAMP reaction. The outer primers hybridize a 
few bases of the inner and initiate the DNA synthesis with strand displacement, forming 
a loop structure, which initiates a DNA synthesis by auto recognition. In this technique, 
10 copies of DNA can be produced in less than one hour [52]. The final products are mul-
tiple loop DNA formed by alignment between inverted repeated sequences present in the 
same chain [53]. It only requires a water bath or thermo block to realize the amplification 
of DNA and the amplified products can be analysed by real time PCR equipment or by 
electrophoresis [54]. This technique is more sensitive than conventional PCR but low sen-
sitive than real time PCR [53]. The LAMP assay has been evaluated identifying REP 529-
bp, SAG1, SAG2 and B1 T. gondii sequences from PBMC [54]. The reported sensitivity was 
0.1 tachyzoites and crossed reactivity with other parasites was not found. The detection of 
SAG2 showed the higher sensitivity (87.5%) followed by SAG-1 (80%) and B1 (80%). The 
specificity was 100% in all of them [55]. However, all techniques of nucleic acid amplifi-
cation have a high sensitivity, for that reason a rigorous quality control is necessary to 
discard false positives.
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4.5. Polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLPs)
The PCR-RFLP is based on the capacity of restriction endonucleases that recognize polymor-
phisms of only one nucleotide (SNPs). Polymerase chain reaction (PCR) products treated 
with restriction enzymes to generate polymorphic DNA fragments of variable length, that are 
visualized after electrophoresis in agarose or polyacrylamide gels with a band pattern [55]. 
In 1995, Howe and Sibley identified three main linages (type I, II and III) from 106 strains of 
T. gondii isolated from humans and animals by PCR-RFLP using six markers [56].
Since then, in different laboratories, several groups of different multi-locus markers have 
been selected, to characterize by PCR-RFLP T. gondii isolates from persons and animals [57, 
58]. Currently, there has been developed a method for T. gondii classification into genotypes 
known as multiplex nested PCR-RFLPs (Mn-PCR-RFLPs). This method uses 10 genetic 
markers including the gens SAG1, SAG2, SAG3, Btub, GRA6, C22-8, c29-2, L358, PK1 and 
apico [59]. The Mn-PCR-RFLP has been applied broadly in the typing of positive clinically 
samples and has generated a big amount of data about the genetic diversity of the parasite [60, 
61]. As in all techniques, where DNA amplification is performed, several negative controls 
must be included to have a strict quality control.
The microsatellites (MS) are short tandem repeats (STR) sequences of DNA (2 to 6 pb), that are 
widely distributed throughout the nuclear genomes of eukaryotes. They are highly polymor-
phic, the MS length varies depending the numbers of STR. The tandem repetitions in T. gondii 
are often simple, with only repetitions of two nucleotides, which occur from 2 to 20 times [62, 
63]. Around 15 markers of MS have been used, including (tub2, W35, TgM-A, B18, B17; M33, 
IV.1, XI.1, M48, M102, N60, N82, AA, N61, N83) to determine the genotype of T. gondii in differ-
ent laboratories [61, 62]. Ajzenberg et al. developed an easy method to genotype T. gondii in one 
multiplex PCR using 15 MS markers, in which eight MS markers (tub2, W35, TgM-A, B18, B17, 
M33, IV.1 and XI.1) could differentiate the types I, II and III from all the atypical genotypes, and 
the other seven markers (M48, M102, N60, N82, AA, N61, N83 ) could improve the resolution 
from the genetic differentiation of strictly related isolates in an haplo-group or clonal linage [62, 
63]. The multiplex 15-MS assay is the best available tool to characterize T. gondii from geneti-
cally different or identical isolates during an outbreak, laboratory contamination and from 
mixed infections. The limitation of this assay is the request of an automatized sequencer with 
the ‘gene scan’ tool. The disadvantage is that samples with poor DNA can cause low intensity 
signals, generating non-specific PCR products [61, 62].
4.6. High-resolution melting (HRM)
In homogeny sample, the HRM method can analyse genetic variations, which allows to char-
acterize polymorphisms based on the melting temperature generated by the DNA length and 
GC content [62]. On the base of only one SNP from gene B1 which is found in multiple copies, 
the HRM can classify correctly three different types of strains of T. gondii [63]. This assay was 
developed to determine the genotype of T. gondii directly from biological samples, with a better 
genotyping when use multiple copy genes in comparison to one copy genes, avoiding a cellular 
culture or bioassay.
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